Jefferson University Hospitals

Physician Profile

Pramila Rani Anne, MD

Academic Title: Associate Professor

Specialties
Radiation Oncology
Radiation Oncology - Breast Cancer
Radiation Oncology - Colorectal Cancer
Radiation Oncology - Esophageal Cancer
Radiation Oncology - Gastrointestinal (GI) Cancer
Radiation Oncology - Gynecologic Cancer
Radiation Oncology - Head & Neck Cancer
Radiation Oncology - Liver Cancer
Radiation Oncology - Melanoma/Skin Cancer
Radiation Oncology - Pancreatic Cancer
Radiation Oncology - Soft Tissue Sarcoma
Radiation Oncology - Stomach Cancer

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
Bodine Center, Suite G-301
111 South 11th Street
Philadelphia PA 19107
Phone: (215) 955-6702
Fax: (215) 955-0412

Medical Services

Years in Practice

22

Board Certifications

  • Radiation Oncology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016

Education

  • University of Virginia, Medical School

Internship

  • Riverside Regional Medical Center

Residency

  • Massachusetts General Hospital, Boston, MA

Recent Publications

Increasing faculty participation in resident education and providing cost-effective self-assessment module credit to faculty through resident-generated didactics

Eastern cooperative oncology group and american college of radiology imaging network randomized phase 2 trial of neoadjuvant preoperative paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design

Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography

Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold

Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial

NRG oncology radiation therapy oncology group 0822: A phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer

Efficacy endpoints of radiation therapy group protocol 0247: A randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer

Conditional survival probabilities for patients with resected pancreatic adenocarcinoma

Radiation therapy use and outcomes among older women with ER-Positive and ER-negative stage I breast cancer

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer

Impact of a radiation oncology elective on the careers of young physicians: Update on a prospective cohort study

Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer

Head and neck carcinoma in the United States: First comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)

Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies

Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school

Radiation therapy in breast-conserving therapy for invasive breast cancer

Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer

Implementation and experimental results of 4D tumor tracking using robotic couch

Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center

The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma